The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine

Arthritis & Rheumatism

Volumn 38, Issue 8, 1995, Pages 1040-1045

  Cronstein, Bruce N ^c   Naime, Dwight ^a   Firestein, Gary ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b Gensia Inc   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 3 BROMOPYRAZOLO[3,4 D]PYRIMIDINE 1 (5 AMINO 5 DEOXYRIBOSIDE); ADENOSINE KINASE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ENZYME INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; INFLAMMATION; LEUKOCYTE COUNT; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE KINASE; ANIMAL; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; LEUKOCYTES; MICE; MICE, INBRED BALB C; RECEPTORS, PURINERGIC P1; RIBONUCLEOSIDES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THEOBROMINE; TUMOR NECROSIS FACTOR; XANTHINES;

EID: 0029118909     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780380804     Document Type: Article

References (25)

1. The antiinflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation
2. Protective effect of an adenosine kinase inhibitor in septic shock
3. Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor: the role of selectins
4. Suppression of acute and chronic inflammation in adrenalectomized rats by pharmacologic amounts of prostaglandins
5. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils
6. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase‐deficient patients
7. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor‐alpha production and protect mice against endotoxin challenge
8. Antiinflammatory effects of an adenosine kinase inhibitor: decreased neutrophil accumulation and vascular leakage
9. Inhibition of 5‐aminoimidazole‐4‐carboxamide ribotide transformylase, adenosine deaminase and 5′‐adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5‐aminoimidazole‐4‐carboxamide riboside and ribotide
10. Inhibition of folate‐dependent enzymes by non‐steroidal antiinflammatory drugs
11. Antifolates in rheumatoid arthritis: a hypothetical mechanism of action
12. Increased adenosine concentration in blood from ischemic myocardium by AICA riboside: effects on flow, granulocytes and injury
13. Selective adenosine release from human B but not T lymphoid cell line
14. Alteration of purine metabolism by AICA‐riboside in human B lymphoblasts
15. Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine
16. Nonsteroidal antiinflammatory agents inhibit stimulated neutrophil adhesion to endothelium: adenosine dependent and independent mechanisms
17. Regulation of adenosine kinase by adenosine analogs
18. Adenosine, an endogenous anti‐inflammatory agent
19. Adenosine: an endogenous inhibitor of neutrophil‐mediated injury to endothelial cells
20. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors
21. Adenosine A2 receptors on human monocytes modulate C2 production
22. Impaired immunoregulation in systemic lupus erythematosus: defective adenosineinduced suppressor T lymphocyte generation
23. Abnormal adenosine‐induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus
24. Regulation of human T lymphocyte surface antigen mobility by purinergic receptors
25. Capping of human T‐cell specific determinants: kinetics of capping and receptor reexpression and regulation by the cytoskeleton